Logo image of ACO-X.CA

ATCO LTD -CLASS I (ACO-X.CA) Stock Fundamental Analysis

Canada - Toronto Stock Exchange - TSX:ACO-X - CA0467894006 - Common Stock

57.09 CAD
+0.28 (+0.49%)
Last: 1/9/2026, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, ACO-X scores 4 out of 10 in our fundamental rating. ACO-X was compared to 19 industry peers in the Multi-Utilities industry. ACO-X has only an average score on both its financial health and profitability. ACO-X is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year ACO-X was profitable.
In the past year ACO-X had a positive cash flow from operations.
In the past 5 years ACO-X has always been profitable.
Each year in the past 5 years ACO-X had a positive operating cash flow.
ACO-X.CA Yearly Net Income VS EBIT VS OCF VS FCFACO-X.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

1.2 Ratios

With a Return On Assets value of 1.55%, ACO-X perfoms like the industry average, outperforming 42.11% of the companies in the same industry.
Looking at the Return On Equity, with a value of 9.08%, ACO-X belongs to the top of the industry, outperforming 89.47% of the companies in the same industry.
The Return On Invested Capital of ACO-X (3.73%) is worse than 73.68% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ACO-X is in line with the industry average of 3.73%.
Industry RankSector Rank
ROA 1.55%
ROE 9.08%
ROIC 3.73%
ROA(3y)1.62%
ROA(5y)1.41%
ROE(3y)9.17%
ROE(5y)7.94%
ROIC(3y)3.92%
ROIC(5y)3.81%
ACO-X.CA Yearly ROA, ROE, ROICACO-X.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

ACO-X has a Profit Margin (8.38%) which is comparable to the rest of the industry.
ACO-X's Profit Margin has declined in the last couple of years.
ACO-X's Operating Margin of 24.56% is in line compared to the rest of the industry. ACO-X outperforms 42.11% of its industry peers.
In the last couple of years the Operating Margin of ACO-X has declined.
ACO-X has a Gross Margin (74.90%) which is in line with its industry peers.
In the last couple of years the Gross Margin of ACO-X has remained more or less at the same level.
Industry RankSector Rank
OM 24.56%
PM (TTM) 8.38%
GM 74.9%
OM growth 3Y2.6%
OM growth 5Y-3.18%
PM growth 3Y14.9%
PM growth 5Y-4.41%
GM growth 3Y-0.25%
GM growth 5Y-1.16%
ACO-X.CA Yearly Profit, Operating, Gross MarginsACO-X.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ACO-X is destroying value.
Compared to 1 year ago, ACO-X has about the same amount of shares outstanding.
The number of shares outstanding for ACO-X has been reduced compared to 5 years ago.
Compared to 1 year ago, ACO-X has a worse debt to assets ratio.
ACO-X.CA Yearly Shares OutstandingACO-X.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ACO-X.CA Yearly Total Debt VS Total AssetsACO-X.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

ACO-X has an Altman-Z score of 0.78. This is a bad value and indicates that ACO-X is not financially healthy and even has some risk of bankruptcy.
With an excellent Altman-Z score value of 0.78, ACO-X belongs to the best of the industry, outperforming 84.21% of the companies in the same industry.
ACO-X has a debt to FCF ratio of 27.90. This is a negative value and a sign of low solvency as ACO-X would need 27.90 years to pay back of all of its debts.
ACO-X's Debt to FCF ratio of 27.90 is amongst the best of the industry. ACO-X outperforms 100.00% of its industry peers.
A Debt/Equity ratio of 2.64 is on the high side and indicates that ACO-X has dependencies on debt financing.
ACO-X's Debt to Equity ratio of 2.64 is on the low side compared to the rest of the industry. ACO-X is outperformed by 73.68% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.64
Debt/FCF 27.9
Altman-Z 0.78
ROIC/WACC0.73
WACC5.1%
ACO-X.CA Yearly LT Debt VS Equity VS FCFACO-X.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 1.81 indicates that ACO-X should not have too much problems paying its short term obligations.
The Current ratio of ACO-X (1.81) is better than 100.00% of its industry peers.
ACO-X has a Quick Ratio of 1.66. This is a normal value and indicates that ACO-X is financially healthy and should not expect problems in meeting its short term obligations.
ACO-X has a Quick ratio of 1.66. This is amongst the best in the industry. ACO-X outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.81
Quick Ratio 1.66
ACO-X.CA Yearly Current Assets VS Current LiabilitesACO-X.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 10.19% over the past year.
Measured over the past 5 years, ACO-X shows a small growth in Earnings Per Share. The EPS has been growing by 6.10% on average per year.
Looking at the last year, ACO-X shows a small growth in Revenue. The Revenue has grown by 7.75% in the last year.
ACO-X shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.98% yearly.
EPS 1Y (TTM)10.19%
EPS 3Y8.59%
EPS 5Y6.1%
EPS Q2Q%13.58%
Revenue 1Y (TTM)7.75%
Revenue growth 3Y4.84%
Revenue growth 5Y0.98%
Sales Q2Q%6.09%

3.2 Future

ACO-X is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.90% yearly.
The Revenue is expected to grow by 2.20% on average over the next years.
EPS Next Y8.92%
EPS Next 2Y4.96%
EPS Next 3Y4.9%
EPS Next 5YN/A
Revenue Next Year0%
Revenue Next 2Y1.49%
Revenue Next 3Y2.2%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ACO-X.CA Yearly Revenue VS EstimatesACO-X.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
ACO-X.CA Yearly EPS VS EstimatesACO-X.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

4

4. Valuation

4.1 Price/Earnings Ratio

ACO-X is valuated correctly with a Price/Earnings ratio of 12.57.
ACO-X's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 27.19. ACO-X is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 12.08, ACO-X is valued correctly.
The rest of the industry has a similar Price/Forward Earnings ratio as ACO-X.
The average S&P500 Price/Forward Earnings ratio is at 23.92. ACO-X is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 12.57
Fwd PE 12.08
ACO-X.CA Price Earnings VS Forward Price EarningsACO-X.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

ACO-X's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ACO-X is cheaper than 78.95% of the companies in the same industry.
ACO-X's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ACO-X is cheaper than 63.16% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.79
EV/EBITDA 8.4
ACO-X.CA Per share dataACO-X.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.41
PEG (5Y)2.06
EPS Next 2Y4.96%
EPS Next 3Y4.9%

6

5. Dividend

5.1 Amount

ACO-X has a Yearly Dividend Yield of 3.55%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 5.23, ACO-X's dividend is way lower than its industry peers. On top of this 94.74% of the companies listed in the same industry pay a better dividend than ACO-X!
Compared to an average S&P500 Dividend Yield of 1.92, ACO-X pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.55%

5.2 History

The dividend of ACO-X has a limited annual growth rate of 3.93%.
ACO-X has paid a dividend for at least 10 years, which is a reliable track record.
ACO-X has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)3.93%
Div Incr Years31
Div Non Decr Years34
ACO-X.CA Yearly Dividends per shareACO-X.CA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

ACO-X pays out 52.20% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of ACO-X is growing, but earnings are growing more, so the dividend growth is sustainable.
DP52.2%
EPS Next 2Y4.96%
EPS Next 3Y4.9%
ACO-X.CA Yearly Income VS Free CF VS DividendACO-X.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M
ACO-X.CA Dividend Payout.ACO-X.CA Dividend Payout, showing the Payout Ratio.ACO-X.CA Dividend Payout.PayoutRetained Earnings

ATCO LTD -CLASS I

TSX:ACO-X (1/9/2026, 7:00:00 PM)

57.09

+0.28 (+0.49%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)11-07 2025-11-07/bmo
Earnings (Next)02-25 2026-02-25
Inst Owners27.8%
Inst Owner ChangeN/A
Ins Owners0.69%
Ins Owner ChangeN/A
Market Cap6.40B
Revenue(TTM)5.14B
Net Income(TTM)431.00M
Analysts78.67
Price Target61.49 (7.71%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.55%
Yearly Dividend1.96
Dividend Growth(5Y)3.93%
DP52.2%
Div Incr Years31
Div Non Decr Years34
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.14%
Min EPS beat(2)-3.78%
Max EPS beat(2)8.05%
EPS beat(4)3
Avg EPS beat(4)2.22%
Min EPS beat(4)-3.78%
Max EPS beat(4)8.05%
EPS beat(8)7
Avg EPS beat(8)4.37%
EPS beat(12)9
Avg EPS beat(12)2.66%
EPS beat(16)12
Avg EPS beat(16)4.06%
Revenue beat(2)0
Avg Revenue beat(2)-9.84%
Min Revenue beat(2)-17.7%
Max Revenue beat(2)-1.99%
Revenue beat(4)0
Avg Revenue beat(4)-9.73%
Min Revenue beat(4)-18.52%
Max Revenue beat(4)-0.7%
Revenue beat(8)0
Avg Revenue beat(8)-11.91%
Revenue beat(12)0
Avg Revenue beat(12)-10.29%
Revenue beat(16)1
Avg Revenue beat(16)-9.26%
PT rev (1m)3.35%
PT rev (3m)7.65%
EPS NQ rev (1m)-0.47%
EPS NQ rev (3m)-0.2%
EPS NY rev (1m)-0.34%
EPS NY rev (3m)1.31%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)5.26%
Revenue NY rev (3m)0.61%
Valuation
Industry RankSector Rank
PE 12.57
Fwd PE 12.08
P/S 1.24
P/FCF 13.79
P/OCF 2.62
P/B 1.35
P/tB 1.89
EV/EBITDA 8.4
EPS(TTM)4.54
EY7.95%
EPS(NY)4.73
Fwd EY8.28%
FCF(TTM)4.14
FCFY7.25%
OCF(TTM)21.76
OCFY38.11%
SpS45.88
BVpS42.35
TBVpS30.16
PEG (NY)1.41
PEG (5Y)2.06
Graham Number65.77
Profitability
Industry RankSector Rank
ROA 1.55%
ROE 9.08%
ROCE 4.79%
ROIC 3.73%
ROICexc 3.92%
ROICexgc 4.15%
OM 24.56%
PM (TTM) 8.38%
GM 74.9%
FCFM 9.02%
ROA(3y)1.62%
ROA(5y)1.41%
ROE(3y)9.17%
ROE(5y)7.94%
ROIC(3y)3.92%
ROIC(5y)3.81%
ROICexc(3y)4.06%
ROICexc(5y)3.97%
ROICexgc(3y)4.27%
ROICexgc(5y)4.16%
ROCE(3y)5.04%
ROCE(5y)4.9%
ROICexgc growth 3Y1.58%
ROICexgc growth 5Y-6.25%
ROICexc growth 3Y1.11%
ROICexc growth 5Y-6.55%
OM growth 3Y2.6%
OM growth 5Y-3.18%
PM growth 3Y14.9%
PM growth 5Y-4.41%
GM growth 3Y-0.25%
GM growth 5Y-1.16%
F-Score7
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 2.64
Debt/FCF 27.9
Debt/EBITDA 5.96
Cap/Depr 234.56%
Cap/Sales 38.4%
Interest Coverage 2.33
Cash Conversion 115.87%
Profit Quality 107.66%
Current Ratio 1.81
Quick Ratio 1.66
Altman-Z 0.78
F-Score7
WACC5.1%
ROIC/WACC0.73
Cap/Depr(3y)212.07%
Cap/Depr(5y)195.52%
Cap/Sales(3y)33.77%
Cap/Sales(5y)31.75%
Profit Quality(3y)134.57%
Profit Quality(5y)187.54%
High Growth Momentum
Growth
EPS 1Y (TTM)10.19%
EPS 3Y8.59%
EPS 5Y6.1%
EPS Q2Q%13.58%
EPS Next Y8.92%
EPS Next 2Y4.96%
EPS Next 3Y4.9%
EPS Next 5YN/A
Revenue 1Y (TTM)7.75%
Revenue growth 3Y4.84%
Revenue growth 5Y0.98%
Sales Q2Q%6.09%
Revenue Next Year0%
Revenue Next 2Y1.49%
Revenue Next 3Y2.2%
Revenue Next 5YN/A
EBIT growth 1Y25.67%
EBIT growth 3Y7.57%
EBIT growth 5Y-2.22%
EBIT Next Year433.88%
EBIT Next 3Y81.02%
EBIT Next 5YN/A
FCF growth 1Y1.09%
FCF growth 3Y-8.79%
FCF growth 5Y2.94%
OCF growth 1Y16.42%
OCF growth 3Y5.63%
OCF growth 5Y7.34%

ATCO LTD -CLASS I / ACO-X.CA FAQ

What is the ChartMill fundamental rating of ATCO LTD -CLASS I (ACO-X.CA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ACO-X.CA.


What is the valuation status of ATCO LTD -CLASS I (ACO-X.CA) stock?

ChartMill assigns a valuation rating of 4 / 10 to ATCO LTD -CLASS I (ACO-X.CA). This can be considered as Fairly Valued.


What is the profitability of ACO-X stock?

ATCO LTD -CLASS I (ACO-X.CA) has a profitability rating of 4 / 10.


Can you provide the financial health for ACO-X stock?

The financial health rating of ATCO LTD -CLASS I (ACO-X.CA) is 5 / 10.


What is the expected EPS growth for ATCO LTD -CLASS I (ACO-X.CA) stock?

The Earnings per Share (EPS) of ATCO LTD -CLASS I (ACO-X.CA) is expected to grow by 8.92% in the next year.